Veronika Wagner

Title: Veronika Wagner: Pioneering Innovations in RNA Biotechnology

Introduction

Veronika Wagner, an innovative inventor based in Ellwangen, Germany, has made significant contributions to the field of RNA biotechnology. With a track record of three patents, her work focuses on methods that enhance RNA processing and synthesis, positioning her as a notable figure in the realm of molecular biology.

Latest Patents

Wagner's latest patents include groundbreaking innovations such as the "Method for adding cap structures to RNA using immobilized enzymes." This invention centers on the utilization of immobilized capping enzymes, particularly the Vaccinia virus capping enzyme, which facilitates the addition of a 5′-cap structure to RNAs. The invention also covers the development of a novel enzyme reactor designed for performing capping reactions and separating the 5′-capped RNA products.

Another significant patent is "Linear double stranded DNA coupled to a single support or a tag and methods for producing said linear double stranded DNA." This invention pertains to linear double stranded DNA linked to a support or tag at the 3' end of its non-coding strand, expanding the applications of this DNA in RNA in vitro transcription reactions.

Career Highlights

Wagner has collaborated with prominent companies such as CureVac SE and CureVac AG, where her expertise in RNA technologies has been invaluable. Her inventive approach and focus on enzymatic applications have helped advance biotechnological processes within these organizations.

Collaborations

Throughout her career, Veronika has worked alongside notable colleagues, including Tilmann Roos and Benyamin Yazdan Panah. These collaborations have enhanced her research and development efforts, allowing for the exchange of innovative ideas and fostering a spirit of teamwork in the pursuit of scientific advancement.

Conclusion

Veronika Wagner continues to shape the future of RNA biotechnology with her innovative inventions and commitment to enhancing bioprocesses. Her contributions, marked by her patents, reflect a deep understanding of molecular mechanisms and a passion for scientific discovery. As the field evolves, her work will undoubtedly play a critical role in advancing RNA therapeutic applications.